Ticker LaunchIPO · MIRM
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) priced its initial public offering on Jul 18, 2019 at $15.00 per share, within its $14.00–$16.00 range, raising $75M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $345.2M. Cooley advised the company and Latham & Watkins advised the underwriters.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company developing therapies for rare liver diseases. Its candidate maralixibat is in Phase 3 development for pediatric progressive familial intrahepatic cholestasis and planned for Alagille syndrome, while volixibat is in development for adult liver diseases.
- Status
- IPO
- Ticker
- MIRM
- Exchange
- Nasdaq Global Market
- Priced
- Jul 18, 2019
- IPO price
- $15.00
- Price range
- $14.00–$16.00
- Raised
- $75M
- Market cap at IPO price
- $345.2M
- First filed
- Jun 21, 2019
- Company counsel
- Cooley
- Underwriters' counsel
- Latham & Watkins
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jun 21, 2019
- Latest amendment Jul 12, 2019
- Final prospectus (424B4) Jul 18, 2019
- All filings on EDGAR CIK 1759425
Other Biotech & pharma IPOs in 2019
- SNDL Inc.SNDL · Aug 1, 2019
- Genmab A/SGMAB · Jul 19, 2019 · $505.9M
- Fulcrum Therapeutics, Inc.FULC · Jul 18, 2019 · $72M
- BridgeBio Pharma, Inc.BBIO · Jun 28, 2019 · $348.5M
- Karuna Therapeutics, Inc.KRTX · Jun 28, 2019 · $89.2M
- Adaptive Biotechnologies CorpADPT · Jun 27, 2019 · $300M